Clinical trials

  • EXL01 (Faecalibacterium prausnitzii single strain, LBP) for Non-small cell lung cancer | Advanced/metastatic non-small cell lung cancer
  • Epcoritamab for Diffuse large B-cell lymphoma
  • ONDANSETRON for Metastatic colorectal cancer|Colorectal cancer with liver metastases
  • Ofatumumab for Relapsing multiple sclerosis
  • PC14586 for Solid tumours with TP53 Y220C mutation (locally advanced or metastatic)
  • EPCORITAMAB for Diffuse large B-cell lymphoma | B-cell lymphoma | Follicular lymphoma (grade 3B)
  • ZELENECTIDE PEVEDOTIN for Urothelial carcinoma | Transitional cell carcinoma
  • TRASTUZUMAB DERUXTECAN for HER2-positive metastatic breast cancer | Advanced breast cancer
  • DEXAMETHASONE PHOSPHATE for Respiratory distress due to upper airway obstruction
  • satralizumab for Anti-NMDAR encephalitis | Anti-LGI1 encephalitis
  • LINVOSELTAMAB for Monoclonal gammopathy of undetermined significance (high-risk) | Smoldering multiple myeloma (non-high-risk)
  • EPCORITAMAB for Chronic lymphocytic leukemia|Richter's syndrome